Hosted by the Institute for Prostate Cancer Research, the symposium features sessions on advances in treatments for newly diagnosed and advanced prostate cancer, discussions on optimizing prevention and early detection, and strategies for personalized, genetically tailored care.
Each year, the IPCR brings together experts in multiple fields to discuss the latest breakthrough in the prevention, detection and treatment of prostate cancer. This half-day, symposium is filled with scientific insights and projections, discussions on technology and patient care, reviews of the latest scientific innovations and landmark research projects changing how scientists view this disease.
Participants will have an insider's perspective on the development of new answers for those affected by the disease.
8:00 a.m. - 8:30 a.m. Check In and Breakfast
8:30 a.m. Introduction | Pete Nelson, M.D.
8:45 a.m. Risk Based Screening and Hereditary Prostate Cancer | Heather Chung, M.D., Ph.D.
9:00 a.m. Polygenic Risk | Burcu Darst, Ph.D.
9:15 a.m. Prostate Cancer Disparities | Yaw Nyame, M.D., M.S., M.B.A.
9:30 a.m. Patient -Centered Pathology Reports: PSMA Imaging | Larry True, M.D.
9:45 a.m. Diagnosing and Staging Prostate Cancer PSMA Imaging | Delphine Chen, M.D.
10:00 a.m. Q&A
10:15 a.m. - 10:30 a.m. Break
10:30 a.m. Surgical Approaches — Technology Drives New Methods | Dan Lin, M.D.
10:45 a.m. Radiation Therapy — Expanding the Opportunities | Emily Weg, M.D.
11:00 a.m. Survivorship — Improving Treatment Outcomes | Judith Hagedorn, M.D.
11:15 a.m. Patient Centered Research: Why adn How | Marty Chakoian
11:30 a.m. Q&A
11:45 a.m. - 1:00 p.m. Lunch & Activities
11:55 a.m. - 1:00 p.m. BACPAC Group Breakout Session
1:00 p.m. Earlier and Combined — New Treatment Paradigms | Mike Schweizer, M.D.
1:15 p.m. Immune Therapy — Challenges & Breakthroughs | John Lee, M.D., Ph.D.
1:30 p.m. PSMA Therapy — Who? What? When? | Amir Iravani, M.D.
1:45 p.m. Q&A
1:55 p.m. Wrap Up | Pete Nelson, M.D.